media – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Notice: Undefined index: path in /data/www/ddu_2017/webapp/channel_drugdu_com/wp-includes/canonical.php on line 392

Notice: Undefined index: path in /data/www/ddu_2017/webapp/channel_drugdu_com/wp-includes/canonical.php on line 392

Notice: Undefined index: path in /data/www/ddu_2017/webapp/channel_drugdu_com/wp-includes/canonical.php on line 570
media – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

An ideal paediatric Infusion Set

An intravenous infusion set works with the help of gravity to deliver medicines, fluids, blood components or whole blood to the patient. It typically consists of a drip chamber, a tube, flow regulator and needle connector. Ddu (Drugdu.com), the leading global pharmaceutical and medical devices online B2B platform, brings a range of infusion sets on its website. Ddu has collaborated with many infusion set suppliers/ manufacturers to provide the best products to its customers. One of the infusion sets available on Ddu is the Disposable pediatric Infusion sets with flow regulator spike, manufactured by Shenyang Comeboard Technology Co., Ltd. This infusion set has features like easy-holding and easy puncturing spike. It consists of a transparent and flexible tube which prevents winding and twisting. It has a regulator which can adjust the flow rate change from minimum to maximum. It has a PVC tube; its length can be customised on customer’s ...
- Source: drugdu
- 249
- September 28, 2018
Hospital stay reduced to half with Danish endocarditis plan

A Danish, multicenter, randomized POET trial revealed that after declared clinically stable on taking intravenous antibiotics in a hospital for one to two weeks, left-sided endocarditis patients could be sent home with a prescription of antibiotics to be taken orally to complete the rest of the treatment. “Shifting to oral antibiotic treatment in stabilized patients with endocarditis was as effective and safe as continued intravenous antibiotic treatment and was given during half the antibiotic treatment period. These novel findings may have a significant impact on future clinical practice for the management of patients who are stable,” Henning Bundgård, MD, said at the annual congress of the European Society of Cardiology. Guiding principles from the ESC and American Heart Association/American College of Cardiology suggest 6 weeks of intravenous antibiotics for the management of infective endocarditis. This reduces the stay in the hospital to half resulting in lowering of the expenses borne by ...
- Source: drugdu
- 139
- September 11, 2018
Regular daytime nap might lead to Alzheimer disease

Varied research is going on throughout the world in order to find the cause and treatment for Alzheimer’s disease. Scientists from the National Institute on Aging (NIA), Johns Hopkins Medicine and the Bloomberg School have reported that the elders who often feel sleepy during day time are three times more prone to Alzheimer’s disease. These study findings were recently published in the journal named SLEEP. Alzheimer’s disease occurs due to the development of beta-amyloid plaques in brain which results in the changes of nerve structure. The risk of this disease can be reduced by following proper exercise, diet as well as cognitive activities. Recently it was discovered that sleep pattern is also a major risk factor. Improper sleep can develop beta-amyloid protein accumulation in later stage of life. But the reason behind this mechanism is still unknown. The research team came to know the role of sleep by conducting a ...
- Source: drugdu
- 203
- September 10, 2018
FDA Grants Approval for Brainsway’s OCD-Treating TMS System

Obsessive-compulsive disorder (OCD) patients are now offered with a new treatment option as the FDA grants de novo approval for Brainsway’s deep transcranial magnetic stimulation (TMS) system.
- Source: Mass Device
- 186
- August 22, 2018
FDA medtech Mental health New Approvals
IgA Antibodies Influence Friendly Gut Bacteria

Japanese Scientists unravel a molecular apparatus via which antibodies control gut bacteria to conserve health. They observed that immunoglobulin A (IgA) antibodies released by the intestines can influence how bacteria express their genes.
- Source: MedicalNewsToday
- 183
- July 30, 2018
gut bacteria Researches
Assembly Biosciences Initiates Phase 2a Trial for its Lead HBV Core Inhibitor

U.S. based public biotechnology company, Assembly Bioscience revealed the launch of two randomized control phase 2a trials for its leading hepatitis B core inhibitor in a press release.
- Source: Healio
- 229
- July 17, 2018
Clinical Trials hepatitis B
China Welcomes Indian Drugmakers, as Trade with U.S. Sees Tension

China opens up its pharmaceutical market to its rather hostile neighbor, India while Beijing and Washington have a tiff over President Donald Trump’s renewed warning of added tariffs on Chinese imports worth $200 billion.
- Source: FiercePharma
- 288
- July 17, 2018
China India Market Views pharmaceutical drugs
Medtech Startup HeartHero Raises $2m in Seed Funding for its AED

$1.5 million was raised in a seed investment round to support the development of its futuristic automated external defibrillators by Hearthero, a medtech startup.
- Source: MassDevice
- 233
- July 17, 2018
Company Insight medtech seed funding
Woman Loses Toenail Due to Fish Pedicure

Nowadays fish pedicures have become a popular form of pedicure where fish eat dead skin off a person’s feat. But a woman in her 20’s from New York approached a doctor when her toenails started becoming abnormal. She told the doctor that she had been having the issue for around 6 months, from the moment she had the fish pedicure. There was no pain but a few breaks in her toenails, due to which the bottom portion of her nails got separated from the upper portion.
- Source: LiveScience
- 204
- July 17, 2018
bacterial infections health tips Researches
Nonadherence to Hepatitis B Medicines Increases Risk of Hepatocellular Carcinoma, Cirrhosis and Mortality

Recent scientific data revealed that the nonadherence to hepatitis B medicines increases the risk for hepatocellular carcinoma and cirrhosis followed by mortality.
- Source: Healio
- 203
- July 17, 2018
hepatitis B liver disease Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

Exhibitions & Activitiesmore

Ddu to Attend CPhI in Shanghai Sharing Insights on International Marketing of the Medical Trade

June 19, 2018
IRANPHARMA EXPO 2018

June 14, 2018
Drugdu.com Launches Digital Marketing Strategy Solution for Pharmaceuticals and Medical Devices at CMEF Shanghai 2018

May 8, 2018
Ddu Attended CPhI North America Great Success with the “Internet + Cross-border medical trade” Marketing Model

May 3, 2018
Ddu’s International Medical Exhibition Attendance Delivering High Results.

April 9, 2018

Market Reportsmore

International study puts AliveCor’s smartphone ECG on par with 12-lead system

November 30, 2018
Best healthcare facilities

September 26, 2018
China’s Import and Export Market Report of Diabetes Drugs

May 4, 2018
China’s Import and Export Market Report of Vitamins

April 11, 2018
China’s Import and Export Market Report of Contraceptive Drugs

March 16, 2018

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.